By Topic

In situ formation of recombinant humanlike collagen-hydroxyapatite nanohybrid through bionic approach

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $31
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

2 Author(s)
Murugan, R. ; Nanobioengineering Laboratory, NUS Nanoscience and Nanotechnology Initiative, Division of Bioengineering, Faculty of Engineering, National University of Singapore, 9 Engineering Drive 1, Singapore 117576, Singapore ; Ramakrishna, S.

Your organization might have access to this article on the publisher's site. To check, click on this link: 

Processing bone graft materials that mimic the chemical composition and structure of natural bone is a good option for the treatment of bone defects. This investigation reports a processing condition for the in situ formation of recombinant humanlike collagen-hydroxyapatite (CHA) nanohybrid with chemical composition and crystal structure quite similar to natural bone through bionic approach. The processed CHA was characterized by various physicochemical methods and the results suggested that HA crystals are nucleated on the collagen domain with an average size of 32 nm, relatively similar to that of biological apatite. The CHA has enhanced bioresorption than HA and mimics the natural bone in composition and structure; thereby it may be considered for bone applications.

Published in:

Applied Physics Letters  (Volume:88 ,  Issue: 19 )